News | January 11, 2024
Lupin launches Varenicline Tablets in US
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Launch innovative vitamin sublingual sprays
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Subscribe To Our Newsletter & Stay Updated
